Quick links: United States | Major Indices | Indices Future | Real-time Commodities | Webinars | Coronavirus | Economic Calendar
8 Mar 2022
Moderna Prepares for Future Pandemic through Human Vaccine Trials against 15 Viruses
The Index Today
Moderna Inc. is gearing up to start human trials for vaccines against 15 highly infectious viruses and their pathogens by 2025.
This program has been instituted to develop vaccines against a wide array of contagious viruses in order to avert another potential pandemic in the future. It comes amid recent criticism against Moderna by activists for not supplying vaccine doses to poor countries soon enough.
As per a statement by Moderna, their agenda involves creating archetypal vaccines against viruses responsible for causing the Middle East Respiratory Syndrome, Ebola, Marburg infection, as well as dengue fever and chikungunya.
According to Bloomberg News, the company has already started human vaccine trials against key viruses, namely the Zika and HIV viruses. The development for the vaccine against Nipah is also underway.
In a statement, Moderna’s CEO Stephane Bancel said, “Since our beginning, we have focused on developing a global health vaccine program. Today, we are renewing that focus by expanding our work to develop vaccines against priority pathogens that threaten global health.”